Last reviewed · How we verify

NCT05072158: PRIDE

Pelvic Floor Disorders Among Sexual Minoritized Women

Terminated Last updated 12 January 2024
What this trial tests

trial testing None, this is an observational study in Sexual Function Disturbances in 18 participants. Terminated before completion.

Timeline
14 October 2021
Primary endpoint
29 June 2022
29 June 2022

Quick facts

Lead sponsorUniversity of New Mexico
StatusTerminated
Study typeOBSERVATIONAL
Enrollment18
Start date14 October 2021
Primary completion29 June 2022
Estimated completion29 June 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of New Mexico

Who can join

18 and older, female only, with Sexual Function Disturbances or Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to perform cognitive interviews to assess how pelvic floor disorders impact sexual functioning in women who have sex with women (WSW). As a secondary objective there will be cognitive interviews to assess perceptions of sexual function questionnaires such as Female Sexual Function Index (FSFI) and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR) in WSW.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sexual Function Disturbances

Currently open trials in the same condition.

Other University of New Mexico trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05072158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing